Andrew provides strategic corporate and governance advice, with a focus on M&A.

Andrew regularly assists international and domestic clients in acquisitions, divestments and strategic arrangements. He is also sought out by directors and executives for his commercial insight and governance advice.

Andrew is ranked in Chambers Asia Pacific 2026, with clients highlighting his "flexible and solutions-focused" approach and that "he is timely, listens carefully to our goals and needs".

Andrew acts for a number of New Zealand’s leading listed companies. He brings overseas experience to his advice, having worked at Freshfields Bruckhaus Deringer in London, with a focus on multi-jurisdictional M&A for infrastructure assets.

“Andrew consistently provides invaluable commercial advice across a wide range of matters, demonstrating exceptional expertise and a deep understanding of our business and industry.”
Corporate/Commercial respondent, Chambers Asia-Pacific

Contributing author to the New Zealand: Private Equity chapter in Legal 500's Comparative Country Guides 2026.

Chambers Global & Chambers Asia-Pacific 2026
Corporate/Commercial

Leading Lawyer

Asia Pacific Legal 500 2026
Corporate/M&A

Leading Partner

Australasian Law Awards 2019
Finalist

NZ Dealmaker of the Year

Work Highlights

Mercury Capital

  • Advising on its sale of Tamaki Health Group, New Zealand’s largest primary healthcare group, to TPG, a global sponsor.  
  • Advising on its sale of NZ Adventure Travel group, a specialist volunteer tourism operator focused on global conservation led travel programmes.

Comvita (NZX-listed)

  • Advising on its $40.5 million capital raising by way of rights offer and strategic placement to Fraser and Neave (SGX-listed).
  • Advising on its proposed Scheme of Arrangement with Florenz.
  • Advising in response to confidential non-binding indicative offers.

The a2 Milk Company (NZX/ASX-listed)

  • Acquisition of Yashili NZ from China Mengniu Dairy Company Limited (HKEX-listed).
  • Divestment of Mataura Valley Milk to Open Country Dairy. This divestment concluded the strategic M&A undertaken by a2 Milk as part of its transformational supply chain reset.
  • Advising on its strategic engagement in the settlement of manufacturing disputes and support for NZX-listed Synlait Milk’s $217.8 million capital raise.

Wet & Forget

Advising the founders of Wet & Forget on the disposal of its global business to leading New Zealand private equity fund, Direct Capital.

Tāmaki Health Group

Acting for the founders of the Tāmaki Health Group in the sale of a 40% shareholding to Mercury Capital.

Family office divestment of Remuera Rise and Bream Bay Villages

Advising a private family office on the sale of the Remuera Rise and Bream Bay retirement villages to Oceania Healthcare, adding high quality independent living and care assets in Auckland and Northland to Oceania’s growing national portfolio

Capital markets transactions, including equity raisings and secondary market transactions for listed companies with international operations and investor bases:

  • Comvita - acting for the company on its $50 million Placement and Accelerated Non-Renounceable Entitlement Offer.

  • Oceania Healthcare - acting for Craigs Investment Partners, Jarden and Macquarie as underwriters of the $301 million block trade of Oceania Healthcare shares.

  • Tilt Renewables - acting for Citigroup and Forsyth Barr as the underwriters of Tilt Renewables’ $260 million accelerated renounceable entitlement offer.

  • Vista Group - acting for the selling shareholders in their block trade of shares in Vista Group

  • Origin Energy / Contact Energy - acting for the underwriters of the $1.8 billion block trade of Origin Energy’s 53.1% of Contact Energy.

  • Xero - acting for Accel Partners in its $132.9 million investment in Xero by private placement.

Takeovers and control transactions, including public company takeovers and schemes of arrangement involving offshore bidders and listed targets:

  • Rakon - advising US-based Bourns, Inc on its $356 million takeover offer for Rakon.

  • Comvita:

    • advising Comvita on its proposed scheme of arrangement with Florenz, with an implied enterprise value of $119 million

    • advising on its response to a non binding indicative offer.

  • Tilt Renewables - advising the underbidder in the contested acquisition of Tilt Renewables by way of Scheme of Arrangement, which was ultimately sold to the successful bidder for $2.7 billion.

  • Metlifecare - advising a confidential hedge-fund on the scheme of arrangement proposed by EQT in connection with the alleged termination for a material adverse change.

  • Methven - advising Methven on its response to its $118 million takeover by GWA Group, effected by scheme of arrangement.

  • Restaurant Brands - advising Finaccess on its $885 million partial takeover of Restaurant Brands 

  • Kathmandu - advising NZX-listed Briscoe Group on its acquisition of a beach-head stake, and then cash and scrip takeover offer, in respect of Kathmandu, valuing Kathmandu at an enterprise value of $418 million.

  • King Country Energy - acting for the King Country Electric Power Trust on the formation of a joint venture with NZX-listed Trustpower, and the subsequent takeover offer for King Country Energy, valuing it at an enterprise value of ~$143 million.

  • Opus International Consultants - advising UEM Edgenta on its participation in the $263 million cross border takeover of Opus International Consultants by WSP Global.

Areas of Expertise

Insights & News